Clinical Trial Update: A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating allogeneic MesenCure for treatment of acute respiratory distress syndrome (ARDS); currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Allogeneic MesenCure (allogeneic mesenchymal stem cell therapy)

Snippet

Sponsor: BonusBio Group Ltd | Conditions: ARDS | Phase 3 | Status: NOT_YET_RECRUITING